Italy, France, and Spain joined Germany, the Netherlands, Ireland, and more temporarily suspending vaccination rollouts of Oxford-AstraZeneca COVID jabs due to reports of blood clots as a side effect. The World Health Organization stresses that there is no evidence linking the two and urges governments to continue vaccinations.
AstraZeneca, already in the late-stage of their phase three vaccine trials, had to pause all trials due to one volunteer developing an unexplained illness. Alongside other Operation Warp Speed Companies, the biopharmaceutical company signed a joint pledge to properly follow scientific and ethical standards in developing a coronavirus vaccine.
The Oxford-AstraZeneca and CanSino vaccine candidates have both shown promising results in their early trials. As they now both enter phase three clinical trials, experts are hopeful that the vaccine candidates would continue to produce good results.